Limitations of current treatments for systemic lupus erythematosus: A patient and physician survey

Lupus

Volumn 22, Issue 8, 2013, Pages 819-826

  Strand, V ^a   Galateanu, C ^b   Pushparajah, D S ^b   Nikai E ^b   Sayers, J ^c   Wood, R ^c   Vollenhoven, Rf Van ^d  

^a STANFORD UNIVERSITY   (United States)

^b UCB PHARMA   (Belgium)

^c ADELPHI REAL WORLD   (United Kingdom)

^d KAROLINSKA INSTITUTE   (Sweden)

Author keywords

fatigue; HRQoL; productivity; SLE

Indexed keywords

CORTICOSTEROID;

ADULT; CROSS-SECTIONAL STUDY; DISEASE ACTIVITY; DISEASE SEVERITY; FATIGUE; FEMALE; HEALTH CARE SURVEY; HUMAN; JOB SATISFACTION; MAJOR CLINICAL STUDY; MALE; PATIENT SATISFACTION; PHYSICIAN; PRESCRIPTION; PRIORITY JOURNAL; PRODUCTIVITY; QUALITY OF LIFE; REVIEW; SOCIAL PARTICIPATION; SYSTEMIC LUPUS ERYTHEMATOSUS; UNEMPLOYMENT;

FATIGUE; HRQOL; PRODUCTIVITY; SLE;

ACTIVITIES OF DAILY LIVING; ADULT; CROSS-SECTIONAL STUDIES; EFFICIENCY; EMPLOYMENT; FATIGUE; FEMALE; GLUCOCORTICOIDS; HEALTH STATUS; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; PATIENT SATISFACTION; QUALITY OF LIFE; SEVERITY OF ILLNESS INDEX;

EID: 84879698176     PISSN: 09612033     EISSN: 14770962     Source Type: Journal    
DOI: 10.1177/0961203313492577     Document Type: Review

References (35)

1. Thumboo J, Strand V. Health-related quality of life in patients with systemic lupus erythematosus: An update. Ann Acad Med Singapore. 2007 ; 36: 115-122
2. Measurement of fatigue on SLE: A systemic review. Arthritis Rheum. 2007 ; 57: 1348-1357
3. Bruce IN, Mak VC, Hallett DC, et al. Factors associated with fatigue in patients with systemic lupus erythematosus. Ann Rheum Dis. 1999 ; 58: 379-381
4. Dobkin PL, Da CD, Fortin PR, et al. Living with lupus: A prospective pan-Canadian study. J Rheumatol. 2001 ; 28: 2442-2448
5. Greco CM, Rudy TE, Manzi S. Effects of disease activity, pain, and distress on activity limitations in patients with systemic lupus erythematosus. J Rheumatol. 2004 ; 31: 260-267
6. Kiani AN, Petri M. Quality-of-life measurements versus disease activity in systemic lupus erythematosus. Curr Rheumatol Rep. 2010 ; 12: 250-258
7. Petri M, Naqibuddin M, Carson KA, et al. Cognitive function in a systemic lupus erythematosus inception cohort. J Rheumatol. 2008 ; 35: 1776-1781
8. McElhone K, Abbott J, Teh LS. A review of health related quality of life in systemic lupus erythematosus. Lupus. 2006 ; 15: 633-643
9. Strand V, Crawford B. Improvement in health-related quality of life in patients with SLE following sustained reductions in anti-dsDNA antibodies. Expert Rev Pharmacoecon Outcomes Res. 2005 ; 5: 317-326
10. Pons-Estel GJ, Alarcon GS, Scofield L, et al. Understanding the epidemiology and progression of systemic lupus erythematosus. Semin Arthritis Rheum. 2010 ; 39: 257-268
11. Krupp LB, LaRocca NG, Muir J, et al. A study of fatigue in systemic lupus erythematosus. J Rheumatol. 1990 ; 17: 1450-1452
12. Tench CM, McCurdie I, White PD, et al. The prevalence and associations of fatigue in systemic lupus erythematosus. Rheumatology (Oxford). 2000 ; 39: 1249-1254
13. Zonana-Nacach A, Roseman JM, McGwin G, et al. Systemic lupus erythematosus in three ethnic groups. VI: Factors associated with fatigue within 5 years of criteria diagnosis. LUMINA Study Group. LUpus in MInority populations: NAture vs Nurture. Lupus. 2000 ; 9: 101-109
14. Baker K, Pope J. Employment and work disability in systemic lupus erythematosus: A systematic review. Rheumatology (Oxford). 2009 ; 48: 281-284
15. Yelin E, Trupin L, Katz P, et al. Work dynamics among persons with systemic lupus erythematosus. Arthritis Rheum. 2007 ; 57: 56-63
16. Gordon C, Isenberg D, Lerstrom K, et al. The substantial burden of systemic lupus erythematosus on the daily lives of patients: A European patient survey. Rheumatology. 2012 ;:
17. Elbirt D, Sthoeger D, Asher I, et al. The management of systemic lupus erythematosus: Facts and controversies. Clin Dermatol. 2010 ; 28: 330-336
18. Lerstrom K, Crimmings M, Govoni M, et al. Disease symptoms and coping strategies in patient with lupus. Presented at: European Lupus Meeting, Porto, Portugal, 6-9 April 2011: P145.
19. Strand V, Chu A. Measuring outcomes in SLE clinical trials. Expert Rev Pharmacoecon Outcomes Res. 2011 ; 11: 455-468
20. Anderson P, Benford M, Harris N, et al. Real-world physician and patient behaviour across countries: Disease-Specific Programmes - a means to understand. Curr Med Res Opin. 2008 ; 24: 3063-3072
21. Wolfe F, Michaud K, Li T, et al. EQ-5D and SF-36 quality of life measures in systemic lupus erythematosus: Comparisons with rheumatoid arthritis, noninflammatory rheumatic disorders, and fibromyalgia. J Rheumatol. 2010 ; 37: 296-304
22. Reilly Associates. WPAI:SHP V2.0, http://www.reillyassociates.net/WPAI- SHP.html Last accessed 4 April 2013.
23. Yellen SB, Cella DF, Webster K, et al. Measuring fatigue and other anemia-related symptoms with the Functional Assessment of Cancer Therapy (FACT) measurement system. J Pain Symptom Manage. 1997 ; 13: 63-74
24. Lai JS, Cook K, Stone A, et al. Classical test theory and item response theory/Rasch model to assess differences between patient-reported fatigue using 7-day and 4-week recall periods. J Clin Epidemiol. 2009 ; 62: 991-997
25. EuroQol - a new facility for the measurement of health-related quality of life. Health Policy. 1990 ; 16: 199-208
26. Huscher D, Merkesdal S, Thiele K, et al. Cost of illness in rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis and systemic lupus erythematosus in Germany. Ann Rheum Dis. 2006 ; 65: 1175-1183
27. Bultink IE, Turkstra F, Dijkmans BA, et al. High prevalence of unemployment in patients with systemic lupus erythematosus: Association with organ damage and health-related quality of life. J Rheumatol. 2008 ; 35: 1053-1057
28. Nived O, Andersson M, Lindgren M, et al. Adherence with advice and prescriptions in SLE is mostly good, but better follow up is needed: A study with a questionnaire. Lupus. 2007 ; 16: 701-706
29. Jonsen A, Bengtsson AA, Nived O, et al. Outcome of neuropsychiatric systemic lupus erythematosus within a defined Swedish population: increased morbidity but low mortality. Rheumatology (Oxford). 2002 ; 41: 1308-1312
30. Mau W, Listing J, Huscher D, et al. Employment across chronic inflammatory rheumatic diseases and comparison with the general population. J Rheumatol. 2005 ; 32: 721-728
31. Boomsma MM, Bijl M, Stegeman CA, et al. Patients' perceptions of the effects of systemic lupus erythematosus on health, function, income, and interpersonal relationships: A comparison with Wegener's granulomatosis. Arthritis Rheum. 2002 ; 47: 196-201
32. Sutcliffe N, Clarke AE, Taylor R, et al. Total costs and predictors of costs in patients with systemic lupus erythematosus. Rheumatology (Oxford). 2001 ; 40: 37-47
33. Clarke AE, Penrod J, Pierre Y, et al. Underestimating the value of women: Assessing the indirect costs of women with systemic lupus erythematosus. Tri-Nation Study Group. J Rheumatol. 2000 ; 27: 2597-2604
34. Gordon C, Clarke AE. Quality of life and economic evaluation in SLE clinical trials. Lupus. 1999 ; 8: 645-654
35. Panopalis P, Petri M, Manzi S, et al. The systemic lupus erythematosus Tri-Nation study: Cumulative indirect costs. Arthritis Rheum. 2007 ; 57: 64-70